Economic analysis of bevacizumab, cetuximab, and panitumumab with fluoropyrimidine-based chemotherapy in the first-line treatment of KRAS wild-type metastatic colorectal cancer (mCRC)

By Lawrence Donna   Maschio Michael   Leahy Kevin J.   Yunger Simon   Easaw Jacob C.   Weinstein Milton C.  

Journal of Medical Economics, Vol. 16, Iss. 12, 2013-12 ,pp. : 1387-1398

Informa Healthcare

Access to resources Recommend Favorite

Medication adherence among patients with psoriasis on traditional systemic and biologics treatment

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 1, 2018-01 ,pp. : e46-e48

John Wiley & Sons Inc

Access to resources Recommend Favorite

Post‐operative survival following metastasectomy for patients receiving BRAF inhibitor therapy is associated with duration of pre‐operative treatment and elective indication

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 8, 2015-06 ,pp. : 980-984

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hypnosis in the Treatment of Anticipatory Nausea and Vomiting in Patients Receiving Cancer Chemotherapy

By  

Oncology, Vol. 59, Iss. 2, 2000-08 ,pp. : 100-104

Karger

Access to resources Recommend Favorite

Incidence of liver injury among cancer patients receiving chemotherapy in an integrated health system

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 4, 2015-04 ,pp. : 427-434

John Wiley & Sons Inc

Access to resources Recommend Favorite